An interventional study of subdiaphragmatic lidocaine sprayed and standard ERAS in Cystectomy and Myomectomy, sponsored by Peking Union Medical College Hospital. Recruiting at 1 site in China. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Peking Union Medical College Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Objective: To evaluate the efficacy of subdiaphragmatic spray of 0.08% lidocaine in relieving postoperative acute pain and psychological status of patients undergoing single-port laparoscopic surgery for benign gynecological diseases, and to provide evidence-based basis for optimizing postoperative analgesic strategies.
Methods: A single-center, prospective randomized controlled study was conducted. A total of 100 patients scheduled for elective single-port laparoscopic surgery due to uterine fibroids, ovarian cysts, or other benign gynecological conditions were selected from the General Gynecology Center of Peking Union Medical College Hospital. They were divided into the experimental group (n=50) and the control group (n=50) using a random number table. The experimental group received 50 ml of 0.08% lidocaine solution sprayed on the bilateral subdiaphragmatic regions at the start of surgery, while the control group underwent standard ERAS without any pharmaceutical intervention in the subdiaphragmatic area. The primary endpoint was the Numerical Rating Scale (NRS) score for resting pain at 6 hours postoperatively. The secondary endpoints included NRS scores at 1, 2, 12, and 24 hours postoperatively, total consumption of analgesics within 48 hours after surgery, incidence of adverse reactions, patient satisfaction, and scores of psychological and sleep scales (Distress Thermometer, GAD-7, etc.) at 30 days postoperatively. SPSS 25.0 software was used for data analysis. Quantitative data were analyzed by t-test or Mann-Whitney U test, and qualitative data were analyzed by χ² test or Fisher's exact test. Repeated measurement data were analyzed by repeated measures analysis of variance.
Results: After the completion of the study, differences in NRS scores, analgesic consumption, psychological status and other indicators between the two groups will be compared.
Conclusion: The results of this study will clarify the clinical value of intraoperative diaphragmatic infiltration with low-concentration lidocaine in postoperative analgesia after single-port laparoscopic gynecological surgery, and provide references for postoperative pain management and psychological intervention.
Peking Union Medical College Hospital is the lead sponsor of 1,158 studies on the registry; 477 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
After adjusting the patient's position, a catheter is inserted through the single-port laparoscopic operating channel, and 50ml of 0.08% lidocaine solution is evenly sprayed on the bilateral subdiaphragmatic regions under laparoscopic direct vision.
Other: subdiaphragmatic lidocaine sprayed
Standard Enhanced Recovery After Surgery (ERAS) protocol for single-port laparoscopic surgery is performed, with no drug intervention in the subdiaphragmatic region at the end of surgery.
Procedure: standard ERAS
After adjusting the patient's position, a catheter is inserted through the single-port laparoscopic operating channel, and 50ml of 0.08% lidocaine solution is evenly sprayed on the bilateral subdiaphragmatic regions under laparoscopic direct vision.
Standard Enhanced Recovery After Surgery (ERAS) protocol for single-port laparoscopic surgery is performed, with no drug intervention in the subdiaphragmatic region at the end of surgery.
Numerical Rating Scale (NRS) score at rest 6 hours postoperatively
NRS: range from 0\~10, with 10 the heaviest pain
Time frame: From operation to 6 hours after operation
NRS scores at rest 1, 2, 12, and 24 hours postoperatively
NRS: range from 0\~10, with 10 the heaviest pain
Time frame: from operation to 1, 2, 12, and 24 hours after operation
Total consumption of postoperative analgesic drugs:type of additional postoperative analgesic drugs
type of additional postoperative analgesic drugs used after operation, besides standard ERAS protocol
Time frame: from operation to 48 hours after operation
Total consumption of postoperative analgesic drugs: dosage of additional postoperative analgesic drugs
dosage of additional postoperative analgesic drugs used after operation, besides standard ERAS protocol
Time frame: from operation to 48 hours after operation
Incidence of postoperative nausea and vomiting
incidence of postoperative nausea or vomiting
Time frame: from operation to 48 hours after operation
Overall patient satisfaction score with postoperative analgesic effect (using a 5-point Likert scale, including five levels: Very Dissatisfied, Dissatisfied, Neutral, Satisfied, Very Satisfied)
Time frame: from operation to 48 hours after operation
Distress Thermometer
Distress Thermometer (DT),0-10,Higher scores indicate worse condition.
Time frame: from enrollment to 30 days after operation
Generalized Anxiety Disorder 7-item Scale (GAD-7)
0-21,Higher scores indicate worse anxiety symptoms
Time frame: from enrollment to 30 days after operation
Patient Health Questionnaire 2-item Scale (PHQ-2)
0-6,Higher scores indicate worse depressive symptom severity
Time frame: from enrollment to 30 days after operation
Patient Health Questionnaire 9-item Scale (PHQ-9)
0-27,Higher scores indicate worse depressive symptoms
Time frame: from enrollment to 30 days after operation
Impact of Event Scale - Revised (IES-R)
0-88,Higher scores indicate worse post-traumatic stress symptoms (intrusions, avoidance, hyperarousal)
Time frame: from enrollment to 30 days after operation
Pittsburgh Sleep Quality Index (PSQI)
0-21,Higher scores indicate worse sleep quality
Time frame: from enrollment to 30 days after operation
Plan to share: No
No publications or documents are linked to this record.
Ran from Apr 2026 to primary completion in Oct 2026, 6 months.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: start Dec 2025 → Apr 2026, primary completion Aug 2026 → Oct 2026 and completion Aug 2026 → Nov 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking Union Medical College Hospital →